Figure 11.
(I) The in-vitro antifungal activity (inhibition Zones) of the selected Nystatin Spanlastical dispersions SP3 and SP6 1 mg/mL (5000IU/mL) along with their blanks, (II) The in-vitro antifungal activity (inhibition Zones) of the Marketed oral suspension Nystatin® with three concentrations (A) Original concentration 20mg/mL (100,000 IU/mL) (B) dilution of 1 mg/mL (5000 IU/mL) (C) dilution of 0.5 mg/mL (2500IU/mL).
